Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
139.93B
Market cap139.93B
Price-Earnings ratio
43.31
Price-Earnings ratio43.31
Dividend yield
0.93%
Dividend yield0.93%
Average volume
2.51M
Average volume2.51M
High today
$372.05
High today$372.05
Low today
$360.88
Low today$360.88
Open price
$365.17
Open price$365.17
Volume
2.05M
Volume2.05M
52 Week high
$404.87
52 Week high$404.87
52 Week low
$329.16
52 Week low$329.16

Stock Snapshot

With a market cap of 139.93B, Stryker(SYK) trades at $365.85. The stock has a price-to-earnings ratio of 43.31 and currently yields dividends of 93.5%.

During the trading session on 2026-02-12, Stryker(SYK) shares reached a daily high of $372.05 and a low of $360.88. At a current price of $365.85, the stock is +1.4% higher than the low and still -1.7% under the high.

Trading activity shows a volume of 2.05M, compared to an average daily volume of 2.51M.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

The stock's 52-week range extends from a low of $329.16 to a high of $404.87.

SYK News

Simply Wall St 6h
Does Stryker’s New Ortho-Robotics Launch and Results Reset the Bull Case For SYK?

In recent days, Stryker has launched the T2 Alpha Humerus Nailing System and begun limited market release of its Mako RPS handheld robotic system for total knee...

Does Stryker’s New Ortho-Robotics Launch and Results Reset the Bull Case For SYK?
Simply Wall St 3d
Stryker's Earnings Seem To Be Promising

Stryker Corporation's ( ) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some digging, and we think tha...

Stryker's Earnings Seem To Be Promising
Simply Wall St 5d
Stryker Is Due To Pay A Dividend Of $0.88

Stryker Corporation ( ) will pay a dividend of $0.88 on the 30th of April. This takes the annual payment to 1.0% of the current stock price, which unfortunately...

Stryker Is Due To Pay A Dividend Of $0.88

Analyst ratings

78%

of 32 ratings
Buy
78.1%
Hold
18.8%
Sell
3.1%

More SYK News

TipRanks 6d
Top Insider Quietly Unloads a Massive Stake in Medical Device Giant

New insider activity at Stryker ( (SYK) ) has taken place on February 6, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investin...

Simply Wall St 7d
Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs

Stryker (NYSE:SYK) has declared a quarterly dividend that is 4.8% higher year over year. The updated dividend reflects the company’s latest step in returning c...

Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.